BMC Pulmonary Medicine-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=962288, encodeId=de6a96228874, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：original article换了新的投稿系统了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Sun May 02 15:29:13 CST 2021, time=2021-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054839, encodeId=ff4d10548395c, content=第一次投这个杂志，一审两个月，让大修，修回稿投过去后1周直接录用，然后2周左右就online，我现在版面费还没有交，pubmed上居然已经可以检索到了。这个杂志这么友好的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76595209770, createdName=huanhuan871002_19261827, createdTime=Sun Sep 26 06:47:10 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101851, encodeId=995e2101851f0, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肺栓塞 经验分享：审稿周期整整2个月，已被拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoFHUBxzOaItc0fTfYbjUiaBIibyggAAXcguuV2cBVc0jzWT3yZgUCcpD6Dic4jMIicFK3LaQAe12giadQ/132, createdBy=f2891730419, createdName=大爱无声504, createdTime=Mon Nov 21 22:28:26 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099710, encodeId=68132099e1007, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=48f55544498, createdName=ms1000001839800568, createdTime=Thu Nov 10 18:10:21 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241831, encodeId=da48124183196, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：20220330submitted 20220410editor invited 20220610 revision requested 20220710 revision quality check in process editor evaluating revision 20220717 2 Reviewer(s) invited 20220724 1 reviewer accepted 20220810 1 Reviewer report received 20220812 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5dcb5518639, createdName=ms3000000066338503, createdTime=Mon Aug 29 14:06:07 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090674, encodeId=461e20906e471, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺疾病;肿瘤;肺肿瘤 经验分享：6.12 First submitted 6.15 Editor invited 6.25 Reviewers invited 7.3 Reviews received 8.9 Major revision 8.19 Submitted 9.8 Reviewers invited 9.20 Major revision 9.27 Accepted 三个月时间，大修了两次，因为条件原因无法补实验，但是最终还是接收了，编辑真的很不错！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80638145994, createdName=ms6000001354647172, createdTime=Tue Sep 27 18:27:07 CST 2022, time=2022-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926883, encodeId=ff66926883af, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肺疾病;分子机制 经验分享：版面费2490美元，速度较慢，对文章质量要求不高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c901619173, createdName=squidbear, createdTime=Wed Feb 24 15:48:36 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248889, encodeId=becb1248889f8, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺肿瘤 经验分享：上个月22号编辑已经收到审稿人的报告了。到现在已经过了23天了,还不给我消息。拒绝还是接收还是修改也不说一声,审稿属实有点慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2dcf8225439, createdName=ms3000001610578449, createdTime=Wed Sep 14 15:34:02 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072179, encodeId=a41410e21790f, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺疾病;呼吸科 经验分享：一审20天左右返回意见，提了很多问题，改了近1个月，二审1周就回来啦，这次提的问题很少啦，又改了1个月，返回去第2天直接接收，到现在还没交版面费，只收到一份接收邮箱，求问下一步, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b09a2038763, createdName=张小米--, createdTime=Sat Nov 20 12:13:19 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123633, encodeId=682e212363326, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺癌 经验分享：2022年10月15日转投，1月8号大修，然后1月29修回，3月22小修（格式问题），3月23修回，4月3accept。总体速度可以，一审时间有点久，当初发邮件给编辑部问了一下。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08cd5169632, createdName=146d3b97m12(暂无昵称), createdTime=Tue Apr 04 10:28:17 CST 2023, time=2023-04-04, status=1, ipAttribution=陕西省)]

2021-05-02 爱爬树的松鼠

审稿速度:12.0 | 投稿命中率:50.0
经验分享：original article换了新的投稿系统了吗?

73 32

展开32条回复

[GetPortalCommentsPageByObjectIdResponse(id=962288, encodeId=de6a96228874, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：original article换了新的投稿系统了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Sun May 02 15:29:13 CST 2021, time=2021-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054839, encodeId=ff4d10548395c, content=第一次投这个杂志，一审两个月，让大修，修回稿投过去后1周直接录用，然后2周左右就online，我现在版面费还没有交，pubmed上居然已经可以检索到了。这个杂志这么友好的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76595209770, createdName=huanhuan871002_19261827, createdTime=Sun Sep 26 06:47:10 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101851, encodeId=995e2101851f0, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肺栓塞 经验分享：审稿周期整整2个月，已被拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoFHUBxzOaItc0fTfYbjUiaBIibyggAAXcguuV2cBVc0jzWT3yZgUCcpD6Dic4jMIicFK3LaQAe12giadQ/132, createdBy=f2891730419, createdName=大爱无声504, createdTime=Mon Nov 21 22:28:26 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099710, encodeId=68132099e1007, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=48f55544498, createdName=ms1000001839800568, createdTime=Thu Nov 10 18:10:21 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241831, encodeId=da48124183196, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：20220330submitted 20220410editor invited 20220610 revision requested 20220710 revision quality check in process editor evaluating revision 20220717 2 Reviewer(s) invited 20220724 1 reviewer accepted 20220810 1 Reviewer report received 20220812 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5dcb5518639, createdName=ms3000000066338503, createdTime=Mon Aug 29 14:06:07 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090674, encodeId=461e20906e471, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺疾病;肿瘤;肺肿瘤 经验分享：6.12 First submitted 6.15 Editor invited 6.25 Reviewers invited 7.3 Reviews received 8.9 Major revision 8.19 Submitted 9.8 Reviewers invited 9.20 Major revision 9.27 Accepted 三个月时间，大修了两次，因为条件原因无法补实验，但是最终还是接收了，编辑真的很不错！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80638145994, createdName=ms6000001354647172, createdTime=Tue Sep 27 18:27:07 CST 2022, time=2022-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926883, encodeId=ff66926883af, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肺疾病;分子机制 经验分享：版面费2490美元，速度较慢，对文章质量要求不高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c901619173, createdName=squidbear, createdTime=Wed Feb 24 15:48:36 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248889, encodeId=becb1248889f8, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺肿瘤 经验分享：上个月22号编辑已经收到审稿人的报告了。到现在已经过了23天了,还不给我消息。拒绝还是接收还是修改也不说一声,审稿属实有点慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2dcf8225439, createdName=ms3000001610578449, createdTime=Wed Sep 14 15:34:02 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072179, encodeId=a41410e21790f, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺疾病;呼吸科 经验分享：一审20天左右返回意见，提了很多问题，改了近1个月，二审1周就回来啦，这次提的问题很少啦，又改了1个月，返回去第2天直接接收，到现在还没交版面费，只收到一份接收邮箱，求问下一步, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b09a2038763, createdName=张小米--, createdTime=Sat Nov 20 12:13:19 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123633, encodeId=682e212363326, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺癌 经验分享：2022年10月15日转投，1月8号大修，然后1月29修回，3月22小修（格式问题），3月23修回，4月3accept。总体速度可以，一审时间有点久，当初发邮件给编辑部问了一下。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08cd5169632, createdName=146d3b97m12(暂无昵称), createdTime=Tue Apr 04 10:28:17 CST 2023, time=2023-04-04, status=1, ipAttribution=陕西省)]

2021-09-26 huanhuan871002_19261827

第一次投这个杂志，一审两个月，让大修，修回稿投过去后1周直接录用，然后2周左右就online，我现在版面费还没有交，pubmed上居然已经可以检索到了。这个杂志这么友好的吗

147 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=962288, encodeId=de6a96228874, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：original article换了新的投稿系统了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Sun May 02 15:29:13 CST 2021, time=2021-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054839, encodeId=ff4d10548395c, content=第一次投这个杂志，一审两个月，让大修，修回稿投过去后1周直接录用，然后2周左右就online，我现在版面费还没有交，pubmed上居然已经可以检索到了。这个杂志这么友好的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76595209770, createdName=huanhuan871002_19261827, createdTime=Sun Sep 26 06:47:10 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101851, encodeId=995e2101851f0, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肺栓塞 经验分享：审稿周期整整2个月，已被拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoFHUBxzOaItc0fTfYbjUiaBIibyggAAXcguuV2cBVc0jzWT3yZgUCcpD6Dic4jMIicFK3LaQAe12giadQ/132, createdBy=f2891730419, createdName=大爱无声504, createdTime=Mon Nov 21 22:28:26 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099710, encodeId=68132099e1007, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=48f55544498, createdName=ms1000001839800568, createdTime=Thu Nov 10 18:10:21 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241831, encodeId=da48124183196, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：20220330submitted 20220410editor invited 20220610 revision requested 20220710 revision quality check in process editor evaluating revision 20220717 2 Reviewer(s) invited 20220724 1 reviewer accepted 20220810 1 Reviewer report received 20220812 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5dcb5518639, createdName=ms3000000066338503, createdTime=Mon Aug 29 14:06:07 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090674, encodeId=461e20906e471, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺疾病;肿瘤;肺肿瘤 经验分享：6.12 First submitted 6.15 Editor invited 6.25 Reviewers invited 7.3 Reviews received 8.9 Major revision 8.19 Submitted 9.8 Reviewers invited 9.20 Major revision 9.27 Accepted 三个月时间，大修了两次，因为条件原因无法补实验，但是最终还是接收了，编辑真的很不错！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80638145994, createdName=ms6000001354647172, createdTime=Tue Sep 27 18:27:07 CST 2022, time=2022-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926883, encodeId=ff66926883af, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肺疾病;分子机制 经验分享：版面费2490美元，速度较慢，对文章质量要求不高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c901619173, createdName=squidbear, createdTime=Wed Feb 24 15:48:36 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248889, encodeId=becb1248889f8, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺肿瘤 经验分享：上个月22号编辑已经收到审稿人的报告了。到现在已经过了23天了,还不给我消息。拒绝还是接收还是修改也不说一声,审稿属实有点慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2dcf8225439, createdName=ms3000001610578449, createdTime=Wed Sep 14 15:34:02 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072179, encodeId=a41410e21790f, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺疾病;呼吸科 经验分享：一审20天左右返回意见，提了很多问题，改了近1个月，二审1周就回来啦，这次提的问题很少啦，又改了1个月，返回去第2天直接接收，到现在还没交版面费，只收到一份接收邮箱，求问下一步, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b09a2038763, createdName=张小米--, createdTime=Sat Nov 20 12:13:19 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123633, encodeId=682e212363326, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺癌 经验分享：2022年10月15日转投，1月8号大修，然后1月29修回，3月22小修（格式问题），3月23修回，4月3accept。总体速度可以，一审时间有点久，当初发邮件给编辑部问了一下。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08cd5169632, createdName=146d3b97m12(暂无昵称), createdTime=Tue Apr 04 10:28:17 CST 2023, time=2023-04-04, status=1, ipAttribution=陕西省)]

2022-11-21 大爱无声504

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：肺栓塞
经验分享：审稿周期整整2个月，已被拒稿

86 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=962288, encodeId=de6a96228874, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：original article换了新的投稿系统了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Sun May 02 15:29:13 CST 2021, time=2021-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054839, encodeId=ff4d10548395c, content=第一次投这个杂志，一审两个月，让大修，修回稿投过去后1周直接录用，然后2周左右就online，我现在版面费还没有交，pubmed上居然已经可以检索到了。这个杂志这么友好的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76595209770, createdName=huanhuan871002_19261827, createdTime=Sun Sep 26 06:47:10 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101851, encodeId=995e2101851f0, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肺栓塞 经验分享：审稿周期整整2个月，已被拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoFHUBxzOaItc0fTfYbjUiaBIibyggAAXcguuV2cBVc0jzWT3yZgUCcpD6Dic4jMIicFK3LaQAe12giadQ/132, createdBy=f2891730419, createdName=大爱无声504, createdTime=Mon Nov 21 22:28:26 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099710, encodeId=68132099e1007, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=48f55544498, createdName=ms1000001839800568, createdTime=Thu Nov 10 18:10:21 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241831, encodeId=da48124183196, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：20220330submitted 20220410editor invited 20220610 revision requested 20220710 revision quality check in process editor evaluating revision 20220717 2 Reviewer(s) invited 20220724 1 reviewer accepted 20220810 1 Reviewer report received 20220812 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5dcb5518639, createdName=ms3000000066338503, createdTime=Mon Aug 29 14:06:07 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090674, encodeId=461e20906e471, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺疾病;肿瘤;肺肿瘤 经验分享：6.12 First submitted 6.15 Editor invited 6.25 Reviewers invited 7.3 Reviews received 8.9 Major revision 8.19 Submitted 9.8 Reviewers invited 9.20 Major revision 9.27 Accepted 三个月时间，大修了两次，因为条件原因无法补实验，但是最终还是接收了，编辑真的很不错！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80638145994, createdName=ms6000001354647172, createdTime=Tue Sep 27 18:27:07 CST 2022, time=2022-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926883, encodeId=ff66926883af, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肺疾病;分子机制 经验分享：版面费2490美元，速度较慢，对文章质量要求不高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c901619173, createdName=squidbear, createdTime=Wed Feb 24 15:48:36 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248889, encodeId=becb1248889f8, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺肿瘤 经验分享：上个月22号编辑已经收到审稿人的报告了。到现在已经过了23天了,还不给我消息。拒绝还是接收还是修改也不说一声,审稿属实有点慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2dcf8225439, createdName=ms3000001610578449, createdTime=Wed Sep 14 15:34:02 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072179, encodeId=a41410e21790f, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺疾病;呼吸科 经验分享：一审20天左右返回意见，提了很多问题，改了近1个月，二审1周就回来啦，这次提的问题很少啦，又改了1个月，返回去第2天直接接收，到现在还没交版面费，只收到一份接收邮箱，求问下一步, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b09a2038763, createdName=张小米--, createdTime=Sat Nov 20 12:13:19 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123633, encodeId=682e212363326, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺癌 经验分享：2022年10月15日转投，1月8号大修，然后1月29修回，3月22小修（格式问题），3月23修回，4月3accept。总体速度可以，一审时间有点久，当初发邮件给编辑部问了一下。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08cd5169632, createdName=146d3b97m12(暂无昵称), createdTime=Tue Apr 04 10:28:17 CST 2023, time=2023-04-04, status=1, ipAttribution=陕西省)]

2022-11-10 ms1000001839800568

审稿速度:24.0 | 投稿命中率:50.0
经验分享：太慢了

48 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=962288, encodeId=de6a96228874, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：original article换了新的投稿系统了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Sun May 02 15:29:13 CST 2021, time=2021-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054839, encodeId=ff4d10548395c, content=第一次投这个杂志，一审两个月，让大修，修回稿投过去后1周直接录用，然后2周左右就online，我现在版面费还没有交，pubmed上居然已经可以检索到了。这个杂志这么友好的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76595209770, createdName=huanhuan871002_19261827, createdTime=Sun Sep 26 06:47:10 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101851, encodeId=995e2101851f0, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肺栓塞 经验分享：审稿周期整整2个月，已被拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoFHUBxzOaItc0fTfYbjUiaBIibyggAAXcguuV2cBVc0jzWT3yZgUCcpD6Dic4jMIicFK3LaQAe12giadQ/132, createdBy=f2891730419, createdName=大爱无声504, createdTime=Mon Nov 21 22:28:26 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099710, encodeId=68132099e1007, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=48f55544498, createdName=ms1000001839800568, createdTime=Thu Nov 10 18:10:21 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241831, encodeId=da48124183196, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：20220330submitted 20220410editor invited 20220610 revision requested 20220710 revision quality check in process editor evaluating revision 20220717 2 Reviewer(s) invited 20220724 1 reviewer accepted 20220810 1 Reviewer report received 20220812 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5dcb5518639, createdName=ms3000000066338503, createdTime=Mon Aug 29 14:06:07 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090674, encodeId=461e20906e471, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺疾病;肿瘤;肺肿瘤 经验分享：6.12 First submitted 6.15 Editor invited 6.25 Reviewers invited 7.3 Reviews received 8.9 Major revision 8.19 Submitted 9.8 Reviewers invited 9.20 Major revision 9.27 Accepted 三个月时间，大修了两次，因为条件原因无法补实验，但是最终还是接收了，编辑真的很不错！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80638145994, createdName=ms6000001354647172, createdTime=Tue Sep 27 18:27:07 CST 2022, time=2022-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926883, encodeId=ff66926883af, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肺疾病;分子机制 经验分享：版面费2490美元，速度较慢，对文章质量要求不高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c901619173, createdName=squidbear, createdTime=Wed Feb 24 15:48:36 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248889, encodeId=becb1248889f8, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺肿瘤 经验分享：上个月22号编辑已经收到审稿人的报告了。到现在已经过了23天了,还不给我消息。拒绝还是接收还是修改也不说一声,审稿属实有点慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2dcf8225439, createdName=ms3000001610578449, createdTime=Wed Sep 14 15:34:02 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072179, encodeId=a41410e21790f, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺疾病;呼吸科 经验分享：一审20天左右返回意见，提了很多问题，改了近1个月，二审1周就回来啦，这次提的问题很少啦，又改了1个月，返回去第2天直接接收，到现在还没交版面费，只收到一份接收邮箱，求问下一步, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b09a2038763, createdName=张小米--, createdTime=Sat Nov 20 12:13:19 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123633, encodeId=682e212363326, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺癌 经验分享：2022年10月15日转投，1月8号大修，然后1月29修回，3月22小修（格式问题），3月23修回，4月3accept。总体速度可以，一审时间有点久，当初发邮件给编辑部问了一下。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08cd5169632, createdName=146d3b97m12(暂无昵称), createdTime=Tue Apr 04 10:28:17 CST 2023, time=2023-04-04, status=1, ipAttribution=陕西省)]

2022-08-29 ms3000000066338503

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤
经验分享：20220330submitted
20220410editor invited
20220610 revision requested
20220710 revision quality check in process
editor evaluating revision
20220717 2 Reviewer(s) invited
20220724 1 reviewer accepted
20220810 1 Reviewer report received
20220812 accept

62 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=962288, encodeId=de6a96228874, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：original article换了新的投稿系统了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Sun May 02 15:29:13 CST 2021, time=2021-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054839, encodeId=ff4d10548395c, content=第一次投这个杂志，一审两个月，让大修，修回稿投过去后1周直接录用，然后2周左右就online，我现在版面费还没有交，pubmed上居然已经可以检索到了。这个杂志这么友好的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76595209770, createdName=huanhuan871002_19261827, createdTime=Sun Sep 26 06:47:10 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101851, encodeId=995e2101851f0, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肺栓塞 经验分享：审稿周期整整2个月，已被拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoFHUBxzOaItc0fTfYbjUiaBIibyggAAXcguuV2cBVc0jzWT3yZgUCcpD6Dic4jMIicFK3LaQAe12giadQ/132, createdBy=f2891730419, createdName=大爱无声504, createdTime=Mon Nov 21 22:28:26 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099710, encodeId=68132099e1007, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=48f55544498, createdName=ms1000001839800568, createdTime=Thu Nov 10 18:10:21 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241831, encodeId=da48124183196, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：20220330submitted 20220410editor invited 20220610 revision requested 20220710 revision quality check in process editor evaluating revision 20220717 2 Reviewer(s) invited 20220724 1 reviewer accepted 20220810 1 Reviewer report received 20220812 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5dcb5518639, createdName=ms3000000066338503, createdTime=Mon Aug 29 14:06:07 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090674, encodeId=461e20906e471, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺疾病;肿瘤;肺肿瘤 经验分享：6.12 First submitted 6.15 Editor invited 6.25 Reviewers invited 7.3 Reviews received 8.9 Major revision 8.19 Submitted 9.8 Reviewers invited 9.20 Major revision 9.27 Accepted 三个月时间，大修了两次，因为条件原因无法补实验，但是最终还是接收了，编辑真的很不错！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80638145994, createdName=ms6000001354647172, createdTime=Tue Sep 27 18:27:07 CST 2022, time=2022-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926883, encodeId=ff66926883af, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肺疾病;分子机制 经验分享：版面费2490美元，速度较慢，对文章质量要求不高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c901619173, createdName=squidbear, createdTime=Wed Feb 24 15:48:36 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248889, encodeId=becb1248889f8, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺肿瘤 经验分享：上个月22号编辑已经收到审稿人的报告了。到现在已经过了23天了,还不给我消息。拒绝还是接收还是修改也不说一声,审稿属实有点慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2dcf8225439, createdName=ms3000001610578449, createdTime=Wed Sep 14 15:34:02 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072179, encodeId=a41410e21790f, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺疾病;呼吸科 经验分享：一审20天左右返回意见，提了很多问题，改了近1个月，二审1周就回来啦，这次提的问题很少啦，又改了1个月，返回去第2天直接接收，到现在还没交版面费，只收到一份接收邮箱，求问下一步, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b09a2038763, createdName=张小米--, createdTime=Sat Nov 20 12:13:19 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123633, encodeId=682e212363326, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺癌 经验分享：2022年10月15日转投，1月8号大修，然后1月29修回，3月22小修（格式问题），3月23修回，4月3accept。总体速度可以，一审时间有点久，当初发邮件给编辑部问了一下。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08cd5169632, createdName=146d3b97m12(暂无昵称), createdTime=Tue Apr 04 10:28:17 CST 2023, time=2023-04-04, status=1, ipAttribution=陕西省)]

2022-09-27 ms6000001354647172

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：肺疾病;肿瘤;肺肿瘤
经验分享：6.12 First submitted 6.15 Editor invited 6.25 Reviewers invited 7.3 Reviews received 8.9 Major revision 8.19 Submitted 9.8 Reviewers invited 9.20 Major revision 9.27 Accepted 三个月时间，大修了两次，因为条件原因无法补实验，但是最终还是接收了，编辑真的很不错！

45 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=962288, encodeId=de6a96228874, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：original article换了新的投稿系统了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Sun May 02 15:29:13 CST 2021, time=2021-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054839, encodeId=ff4d10548395c, content=第一次投这个杂志，一审两个月，让大修，修回稿投过去后1周直接录用，然后2周左右就online，我现在版面费还没有交，pubmed上居然已经可以检索到了。这个杂志这么友好的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76595209770, createdName=huanhuan871002_19261827, createdTime=Sun Sep 26 06:47:10 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101851, encodeId=995e2101851f0, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肺栓塞 经验分享：审稿周期整整2个月，已被拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoFHUBxzOaItc0fTfYbjUiaBIibyggAAXcguuV2cBVc0jzWT3yZgUCcpD6Dic4jMIicFK3LaQAe12giadQ/132, createdBy=f2891730419, createdName=大爱无声504, createdTime=Mon Nov 21 22:28:26 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099710, encodeId=68132099e1007, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=48f55544498, createdName=ms1000001839800568, createdTime=Thu Nov 10 18:10:21 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241831, encodeId=da48124183196, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：20220330submitted 20220410editor invited 20220610 revision requested 20220710 revision quality check in process editor evaluating revision 20220717 2 Reviewer(s) invited 20220724 1 reviewer accepted 20220810 1 Reviewer report received 20220812 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5dcb5518639, createdName=ms3000000066338503, createdTime=Mon Aug 29 14:06:07 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090674, encodeId=461e20906e471, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺疾病;肿瘤;肺肿瘤 经验分享：6.12 First submitted 6.15 Editor invited 6.25 Reviewers invited 7.3 Reviews received 8.9 Major revision 8.19 Submitted 9.8 Reviewers invited 9.20 Major revision 9.27 Accepted 三个月时间，大修了两次，因为条件原因无法补实验，但是最终还是接收了，编辑真的很不错！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80638145994, createdName=ms6000001354647172, createdTime=Tue Sep 27 18:27:07 CST 2022, time=2022-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926883, encodeId=ff66926883af, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肺疾病;分子机制 经验分享：版面费2490美元，速度较慢，对文章质量要求不高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c901619173, createdName=squidbear, createdTime=Wed Feb 24 15:48:36 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248889, encodeId=becb1248889f8, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺肿瘤 经验分享：上个月22号编辑已经收到审稿人的报告了。到现在已经过了23天了,还不给我消息。拒绝还是接收还是修改也不说一声,审稿属实有点慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2dcf8225439, createdName=ms3000001610578449, createdTime=Wed Sep 14 15:34:02 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072179, encodeId=a41410e21790f, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺疾病;呼吸科 经验分享：一审20天左右返回意见，提了很多问题，改了近1个月，二审1周就回来啦，这次提的问题很少啦，又改了1个月，返回去第2天直接接收，到现在还没交版面费，只收到一份接收邮箱，求问下一步, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b09a2038763, createdName=张小米--, createdTime=Sat Nov 20 12:13:19 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123633, encodeId=682e212363326, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺癌 经验分享：2022年10月15日转投，1月8号大修，然后1月29修回，3月22小修（格式问题），3月23修回，4月3accept。总体速度可以，一审时间有点久，当初发邮件给编辑部问了一下。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08cd5169632, createdName=146d3b97m12(暂无昵称), createdTime=Tue Apr 04 10:28:17 CST 2023, time=2023-04-04, status=1, ipAttribution=陕西省)]

2021-02-24 squidbear

审稿速度:3.0 | 投稿命中率:75.0
偏重的研究方向：肺疾病;分子机制
经验分享：版面费2490美元，速度较慢，对文章质量要求不高

157 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=962288, encodeId=de6a96228874, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：original article换了新的投稿系统了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Sun May 02 15:29:13 CST 2021, time=2021-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054839, encodeId=ff4d10548395c, content=第一次投这个杂志，一审两个月，让大修，修回稿投过去后1周直接录用，然后2周左右就online，我现在版面费还没有交，pubmed上居然已经可以检索到了。这个杂志这么友好的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76595209770, createdName=huanhuan871002_19261827, createdTime=Sun Sep 26 06:47:10 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101851, encodeId=995e2101851f0, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肺栓塞 经验分享：审稿周期整整2个月，已被拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoFHUBxzOaItc0fTfYbjUiaBIibyggAAXcguuV2cBVc0jzWT3yZgUCcpD6Dic4jMIicFK3LaQAe12giadQ/132, createdBy=f2891730419, createdName=大爱无声504, createdTime=Mon Nov 21 22:28:26 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099710, encodeId=68132099e1007, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=48f55544498, createdName=ms1000001839800568, createdTime=Thu Nov 10 18:10:21 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241831, encodeId=da48124183196, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：20220330submitted 20220410editor invited 20220610 revision requested 20220710 revision quality check in process editor evaluating revision 20220717 2 Reviewer(s) invited 20220724 1 reviewer accepted 20220810 1 Reviewer report received 20220812 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5dcb5518639, createdName=ms3000000066338503, createdTime=Mon Aug 29 14:06:07 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090674, encodeId=461e20906e471, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺疾病;肿瘤;肺肿瘤 经验分享：6.12 First submitted 6.15 Editor invited 6.25 Reviewers invited 7.3 Reviews received 8.9 Major revision 8.19 Submitted 9.8 Reviewers invited 9.20 Major revision 9.27 Accepted 三个月时间，大修了两次，因为条件原因无法补实验，但是最终还是接收了，编辑真的很不错！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80638145994, createdName=ms6000001354647172, createdTime=Tue Sep 27 18:27:07 CST 2022, time=2022-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926883, encodeId=ff66926883af, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肺疾病;分子机制 经验分享：版面费2490美元，速度较慢，对文章质量要求不高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c901619173, createdName=squidbear, createdTime=Wed Feb 24 15:48:36 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248889, encodeId=becb1248889f8, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺肿瘤 经验分享：上个月22号编辑已经收到审稿人的报告了。到现在已经过了23天了,还不给我消息。拒绝还是接收还是修改也不说一声,审稿属实有点慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2dcf8225439, createdName=ms3000001610578449, createdTime=Wed Sep 14 15:34:02 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072179, encodeId=a41410e21790f, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺疾病;呼吸科 经验分享：一审20天左右返回意见，提了很多问题，改了近1个月，二审1周就回来啦，这次提的问题很少啦，又改了1个月，返回去第2天直接接收，到现在还没交版面费，只收到一份接收邮箱，求问下一步, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b09a2038763, createdName=张小米--, createdTime=Sat Nov 20 12:13:19 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123633, encodeId=682e212363326, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺癌 经验分享：2022年10月15日转投，1月8号大修，然后1月29修回，3月22小修（格式问题），3月23修回，4月3accept。总体速度可以，一审时间有点久，当初发邮件给编辑部问了一下。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08cd5169632, createdName=146d3b97m12(暂无昵称), createdTime=Tue Apr 04 10:28:17 CST 2023, time=2023-04-04, status=1, ipAttribution=陕西省)]

2022-09-14 ms3000001610578449

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：肺肿瘤
经验分享：上个月22号编辑已经收到审稿人的报告了。到现在已经过了23天了,还不给我消息。拒绝还是接收还是修改也不说一声,审稿属实有点慢

46 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=962288, encodeId=de6a96228874, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：original article换了新的投稿系统了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Sun May 02 15:29:13 CST 2021, time=2021-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054839, encodeId=ff4d10548395c, content=第一次投这个杂志，一审两个月，让大修，修回稿投过去后1周直接录用，然后2周左右就online，我现在版面费还没有交，pubmed上居然已经可以检索到了。这个杂志这么友好的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76595209770, createdName=huanhuan871002_19261827, createdTime=Sun Sep 26 06:47:10 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101851, encodeId=995e2101851f0, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肺栓塞 经验分享：审稿周期整整2个月，已被拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoFHUBxzOaItc0fTfYbjUiaBIibyggAAXcguuV2cBVc0jzWT3yZgUCcpD6Dic4jMIicFK3LaQAe12giadQ/132, createdBy=f2891730419, createdName=大爱无声504, createdTime=Mon Nov 21 22:28:26 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099710, encodeId=68132099e1007, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=48f55544498, createdName=ms1000001839800568, createdTime=Thu Nov 10 18:10:21 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241831, encodeId=da48124183196, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：20220330submitted 20220410editor invited 20220610 revision requested 20220710 revision quality check in process editor evaluating revision 20220717 2 Reviewer(s) invited 20220724 1 reviewer accepted 20220810 1 Reviewer report received 20220812 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5dcb5518639, createdName=ms3000000066338503, createdTime=Mon Aug 29 14:06:07 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090674, encodeId=461e20906e471, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺疾病;肿瘤;肺肿瘤 经验分享：6.12 First submitted 6.15 Editor invited 6.25 Reviewers invited 7.3 Reviews received 8.9 Major revision 8.19 Submitted 9.8 Reviewers invited 9.20 Major revision 9.27 Accepted 三个月时间，大修了两次，因为条件原因无法补实验，但是最终还是接收了，编辑真的很不错！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80638145994, createdName=ms6000001354647172, createdTime=Tue Sep 27 18:27:07 CST 2022, time=2022-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926883, encodeId=ff66926883af, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肺疾病;分子机制 经验分享：版面费2490美元，速度较慢，对文章质量要求不高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c901619173, createdName=squidbear, createdTime=Wed Feb 24 15:48:36 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248889, encodeId=becb1248889f8, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺肿瘤 经验分享：上个月22号编辑已经收到审稿人的报告了。到现在已经过了23天了,还不给我消息。拒绝还是接收还是修改也不说一声,审稿属实有点慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2dcf8225439, createdName=ms3000001610578449, createdTime=Wed Sep 14 15:34:02 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072179, encodeId=a41410e21790f, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺疾病;呼吸科 经验分享：一审20天左右返回意见，提了很多问题，改了近1个月，二审1周就回来啦，这次提的问题很少啦，又改了1个月，返回去第2天直接接收，到现在还没交版面费，只收到一份接收邮箱，求问下一步, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b09a2038763, createdName=张小米--, createdTime=Sat Nov 20 12:13:19 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123633, encodeId=682e212363326, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺癌 经验分享：2022年10月15日转投，1月8号大修，然后1月29修回，3月22小修（格式问题），3月23修回，4月3accept。总体速度可以，一审时间有点久，当初发邮件给编辑部问了一下。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08cd5169632, createdName=146d3b97m12(暂无昵称), createdTime=Tue Apr 04 10:28:17 CST 2023, time=2023-04-04, status=1, ipAttribution=陕西省)]

2021-11-20 张小米--

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：肺疾病;呼吸科
经验分享：一审20天左右返回意见，提了很多问题，改了近1个月，二审1周就回来啦，这次提的问题很少啦，又改了1个月，返回去第2天直接接收，到现在还没交版面费，只收到一份接收邮箱，求问下一步

57 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=962288, encodeId=de6a96228874, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：original article换了新的投稿系统了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Sun May 02 15:29:13 CST 2021, time=2021-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054839, encodeId=ff4d10548395c, content=第一次投这个杂志，一审两个月，让大修，修回稿投过去后1周直接录用，然后2周左右就online，我现在版面费还没有交，pubmed上居然已经可以检索到了。这个杂志这么友好的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76595209770, createdName=huanhuan871002_19261827, createdTime=Sun Sep 26 06:47:10 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101851, encodeId=995e2101851f0, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肺栓塞 经验分享：审稿周期整整2个月，已被拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoFHUBxzOaItc0fTfYbjUiaBIibyggAAXcguuV2cBVc0jzWT3yZgUCcpD6Dic4jMIicFK3LaQAe12giadQ/132, createdBy=f2891730419, createdName=大爱无声504, createdTime=Mon Nov 21 22:28:26 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099710, encodeId=68132099e1007, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=48f55544498, createdName=ms1000001839800568, createdTime=Thu Nov 10 18:10:21 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241831, encodeId=da48124183196, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：20220330submitted 20220410editor invited 20220610 revision requested 20220710 revision quality check in process editor evaluating revision 20220717 2 Reviewer(s) invited 20220724 1 reviewer accepted 20220810 1 Reviewer report received 20220812 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5dcb5518639, createdName=ms3000000066338503, createdTime=Mon Aug 29 14:06:07 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090674, encodeId=461e20906e471, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺疾病;肿瘤;肺肿瘤 经验分享：6.12 First submitted 6.15 Editor invited 6.25 Reviewers invited 7.3 Reviews received 8.9 Major revision 8.19 Submitted 9.8 Reviewers invited 9.20 Major revision 9.27 Accepted 三个月时间，大修了两次，因为条件原因无法补实验，但是最终还是接收了，编辑真的很不错！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80638145994, createdName=ms6000001354647172, createdTime=Tue Sep 27 18:27:07 CST 2022, time=2022-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926883, encodeId=ff66926883af, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肺疾病;分子机制 经验分享：版面费2490美元，速度较慢，对文章质量要求不高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c901619173, createdName=squidbear, createdTime=Wed Feb 24 15:48:36 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248889, encodeId=becb1248889f8, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺肿瘤 经验分享：上个月22号编辑已经收到审稿人的报告了。到现在已经过了23天了,还不给我消息。拒绝还是接收还是修改也不说一声,审稿属实有点慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2dcf8225439, createdName=ms3000001610578449, createdTime=Wed Sep 14 15:34:02 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072179, encodeId=a41410e21790f, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺疾病;呼吸科 经验分享：一审20天左右返回意见，提了很多问题，改了近1个月，二审1周就回来啦，这次提的问题很少啦，又改了1个月，返回去第2天直接接收，到现在还没交版面费，只收到一份接收邮箱，求问下一步, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b09a2038763, createdName=张小米--, createdTime=Sat Nov 20 12:13:19 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123633, encodeId=682e212363326, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺癌 经验分享：2022年10月15日转投，1月8号大修，然后1月29修回，3月22小修（格式问题），3月23修回，4月3accept。总体速度可以，一审时间有点久，当初发邮件给编辑部问了一下。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08cd5169632, createdName=146d3b97m12(暂无昵称), createdTime=Tue Apr 04 10:28:17 CST 2023, time=2023-04-04, status=1, ipAttribution=陕西省)]

2023-04-04 146d3b97m12(暂无昵称) 来自陕西省

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：肺癌
经验分享：2022年10月15日转投，1月8号大修，然后1月29修回，3月22小修（格式问题），3月23修回，4月3accept。总体速度可以，一审时间有点久，当初发邮件给编辑部问了一下。

91 4

展开4条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务